
Prognostic Factors for Intra-Articular Hyaluronic Acid (Euflexxa) Treatment for Knee Osteoarthritis
Cartilage. 2016 Jul;7(3):229-37.
Patients’ data from the FLEXX trial and its subsequent extension trial were analyzed to identify factors associated with effects of intra-articular injection of hyaluronic acid (IA-HA) among patients with knee osteoarthritis (OA). Poorer baseline characteristics of patients, including higher pain score, higher WOMAC subscales, and Kellgren Lawrence (K-L) grade 3 were associated with worse outcomes.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in


Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now